AI Platform Aims to Revolutionize Cancer Immunotherapy

July 28, 2025/in Artificial Intelligence, Immunotherapy, Preclinical Research/by Max

A new AI platform developed by researchers at the Technical University of Denmark and the Scripps Research Institute has dramatically accelerated the design of specialized protein molecules called “minibinders” to enhance cancer immunotherapy. Normally, T cells recognize cancer cells by detecting protein fragments (peptides) presented on their surface by molecules known as pMHCs, but harnessing […]